About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Satiety, Glycemic, and Gastrointestinal Effects of Novel Fibers

NCT00958399·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of Minnesota

With

Tate and Lyle Ingredients France

Age

18–60

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

healthy men and women
age 18-60 years
non-smoking
not taking medication
non-dieting (weight stable in prior 3 months)
BMI 18-27
English literacy
ability to give blood

You may not be if

do not regularly consume breakfast
food allergies to ingredients found in study products
dislike for muffins, fiber bars, or hot cereal
BMI \<18 or \>27
diagnosed cardiovascular, renal, or hepatic disease
diabetes mellitus (fasting blood sugar \>126 mg/dl)
cancer in previous 5 years (except basal cell carcinoma of the skin)
any gastrointestinal disease or condition
recent bacterial infection (\< 3 months)
recent or concurrent participation in an intervention research study
history of drug or alcohol abuse in prior 6 months
use of lipid-lowering, anti-hypertensive, or anti-inflammatory steroid medication
restrained eaters
vegetarians
people who eat more than approximately 15 grams of fiber per day
women who are pregnant or lactating
women with irregular menstrual cycles

The record

StatusCompleted

PhaseNo phase

Taking part20

StartedJul 2008

UpdatedFeb 6, 2012

Conditions

Where1

University of Minnesota - General Clinical Research Center
Minneapolis, Minnesota, United States

Clareo Health | Satiety, Glycemic, and Gastrointestinal Effects of Novel Fibers